Heartland Advisors Inc. Grows Position in Integer Holdings Corporation $ITGR

Heartland Advisors Inc. increased its holdings in Integer Holdings Corporation (NYSE:ITGR) by 2.2% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 247,977 shares of the medical equipment provider’s stock after buying an additional 5,262 shares during the quarter. Integer comprises approximately 1.1% of Heartland Advisors Inc.’s portfolio, making the stock its 12th biggest position. Heartland Advisors Inc.’s holdings in Integer were worth $21,822,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. WINTON GROUP Ltd purchased a new stake in shares of Integer during the 4th quarter valued at about $4,836,000. Jennison Associates LLC bought a new stake in shares of Integer in the fourth quarter worth approximately $1,036,000. Kestrel Investment Management Corp purchased a new position in shares of Integer during the fourth quarter valued at approximately $5,933,000. William Blair Investment Management LLC raised its holdings in shares of Integer by 70.1% during the fourth quarter. William Blair Investment Management LLC now owns 468,377 shares of the medical equipment provider’s stock valued at $36,735,000 after purchasing an additional 192,956 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in shares of Integer by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 3,886,150 shares of the medical equipment provider’s stock valued at $304,791,000 after purchasing an additional 14,465 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Trading Down 4.1%

ITGR stock opened at $95.56 on Friday. Integer Holdings Corporation has a twelve month low of $62.00 and a twelve month high of $116.31. The stock has a market capitalization of $3.25 billion, a price-to-earnings ratio of 23.83, a price-to-earnings-growth ratio of 2.27 and a beta of 0.64. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. The firm’s fifty day simple moving average is $91.53 and its two-hundred day simple moving average is $87.50.

Integer (NYSE:ITGR) last released its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The firm had revenue of $439.58 million during the quarter, compared to the consensus estimate of $426.48 million. During the same quarter last year, the business posted $1.31 EPS. Integer’s revenue was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, analysts anticipate that Integer Holdings Corporation will post 6.04 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th. Piper Sandler reiterated an “overweight” rating and set a $97.00 target price (up from $87.00) on shares of Integer in a research note on Friday, May 1st. Citigroup increased their price target on Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. Truist Financial increased their price target on Integer from $97.00 to $110.00 and gave the company a “buy” rating in a report on Thursday. Finally, Zacks Research downgraded Integer from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th. Four analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Integer presently has a consensus rating of “Hold” and a consensus price target of $101.14.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.